★ Annual Review 2027 tickets now on sale Get your tickets →

News/Compliance & Enforcement/Teva Pharmaceuticals Pays $450 Million to Resolve Anti-Kickback and False Claims Act Violations
Expert Opinion·Compliance & Enforcement Brief

Teva Pharmaceuticals Pays $450 Million to Resolve Anti-Kickback and False Claims Act Violations

Volkov – Teva Pharmaceuticals USA Inc.

🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.
Not ready to join? Take the free Pub K Weekly digest.One email. Free. Top industry articles, the community calendar, and the latest job postings.